Breakthrough medication support for better health through the power of people, science, and technology.
Peer-reviewed publications, clinical trials, case studies and other content on all things med adherence.
We're the company that's solving the decades-old problem of medication nonadherence.
Featured Content
emocha Closes $6.2M Series A Funding Round Led by Claritas Health Ventures
Study Finds Video DOT Could Increase Access to Methadone Treatment and Reduce Risk
Acceptability, feasibility, and outcomes of a clinical pilot program for video observation of methadone take-home dosing during the COVID-19 pandemic
Scene Health Appoints New CFO and Thanks Retiring CFO
RTM Programs Extend Care Beyond Doctors' Visits, Don't Limit Them
Health Equity: The Common Thread Between the 2022 MHPA, AHIP, & Marcus Evans Conferences
emocha Health CEO Urges the Centers for Medicare and Medicaid Services (CMS) to Continue Incorporating Digital Health Monitoring Programs in 2022
emocha Health Responds to Updated Remote Therapeutic Monitoring (RTM) Codes from the Centers for Medicare and Medicaid Services (CMS)
Directly observed therapy to promote medication adherence in adolescent heart transplant recipients
Diving into Health Equity at Modern Healthcare’s Social Determinants of Health Symposium
emocha Health Featured in Three 2022 Gartner Hype Cycles
Programmatic Adoption and Implementation of Video-Observed Therapy in Minnesota: Prospective Observational Cohort Study
Making the Cut: Exploring the Staying Power of Pandemic Era Virtual Care Technologies
emocha Health Sweeps Awards at NCQA and HL7’s Digital Quality Summit Shark Tank Competition
emocha Health on Medication Non-Adherence & Drug Cost Hikes (Healthcare Digital)
More Than a Holiday: Receiving Juneteenth as a Call to Improve Health Equity
3 Things Investors Need to Know About the Growing Digital Healthcare Sector (Nasdaq)
Takeaways from the 2022 National Tuberculosis Controllers Association Conference
emocha Health Announces Appointment of New Executives
Digital Adherence Program Leads to Over 90% Medication Adherence and Improves Outcomes in Pediatric Transplant Patients
Tangible Results in 90 Days: How MedStar Family Choice Engaged Members, Improved Adherence and Boosted its HEDIS Score
Video DOT Implementation During COVID-19 - Three Lessons Learned
90 Days to Improved HEDIS Scores: How a Medicaid MCO Engaged Members, Boosted Adherence, and Improved its AMR Performance
World TB Day 2022 Virtual Roundtable | Video DOT Implementation During COVID-19 – Three Lessons Learned
Beyond PDC & MPR: How Dose-by-Dose Metrics Improve Quality
Virtual Care Better than Retail Pharmacy for Managing Medication Adherence for Chronic and Complex Diseases
What Can the U.S. Government Do in 2022 to Fix Our Broken Healthcare System?
emocha one of five Baltimore startups to watch in 2022
The impact of COVID-19 on the future of healthcare IT
CB Insights Recognizes Scene Health in 2021 ‘Digital Health 150 Ranking’
22 Baltimore tech companies powering telehealth’s expansion
emocha Health Awarded Video Directly Observed Therapy Contract by Texas Department of State Health Services
emocha Health and LifeBridge Health Publish Pediatric Asthma Study Demonstrating Rapid Inhaler Improvement
Remotely delivered incentives to promote buprenorphine treatment engagement in out-of-treatment adults with opioid use disorder
Real-world implementation of video-observed therapy in an urban TB program in the United States
DLA Piper advises Scene Health in US $6.2 million Series A financing
Directly observed therapy to promote medication adherence in paediatric heart transplant recipients
Why Remote, Digital Care Programs Are Especially Important for Disaster Preparedness
A New Solution to an Old Problem: Expanding the Use of HCV+ Organs for Transplantation
World TB Day and the CDC's TB Elimination Champions
emocha Secures Funding from National Institutes of Health to Deploy and Test Digital Medication Adherence Platform to Transplant Recipients
emocha Health Wins the Annual Ostendio MyVCM Trust Network Award for Cybersecurity and Compliance Excellence
Adherence to Direct-Acting Antiviral Therapy in People Actively Using Drugs and Alcohol: The INCLUD Study
emocha Awarded NIH Funding to Help Patients with Opioid Use Disorder Affected by COVID-19
Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized controlled trial
Acceptability and Feasibility of a Mobile Health Application for Video Directly Observed Therapy of Buprenorphine for Opioid Use Disorders in an Office-based Setting
Acceptability and Feasibility of a Behavioral and Mobile Health Intervention (COMBIND) Shown to Increase Uptake of Pevention of Mother to Child Transmission (PMTCT) Care in India
Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study
Evaluation of miLINC to Shorten Time to Treatment for Rifampicin-resistant Mycobacterium Tuberculosis
Use of Smartphone-Based Video Directly Observed Therapy (vDOT) in Tuberculosis Care: Single-Arm, Prospective Feasibility Study
A Multidimensional Electronic Hydroxyurea Adherence Intervention for Children With Sickle Cell Disease: Single-Arm Before-After Study
Provider and Patient Perspectives on Barriers to Buprenorphine Adherence and the Acceptability of Video DOT to Enhance Adherence
Advancing Patient-Centered Care in TB Management: A Mixed-Methods Appraisal of Video DOT
emocha Named to Fast Company’s 2018 Top 10 Most Innovative Companies in Health
Notes from the Field: Use of Asynchronous Video DOT for Treatment of TB and Latent TB Infection in a Long-Term–Care Facility ― Puerto Rico, 2016–2017
Notes from the Field: Tuberculosis Control Activities After Hurricane Harvey - Texas, 2017